News stories about Omnicare (NYSE:OCR) have been trending somewhat positive this week, according to Accern Sentiment. The research firm scores the sentiment of press coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Omnicare earned a media sentiment score of 0.10 on Accern’s scale. Accern also gave news articles about the healthcare company an impact score of 44.433498432976 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.
Omnicare (NYSE OCR) remained flat at $$97.90 during trading hours on Wednesday. The company has a market cap of $9,480.00 and a PE ratio of 60.06.
ILLEGAL ACTIVITY WARNING: “Somewhat Positive News Coverage Somewhat Unlikely to Impact Omnicare (NYSE:OCR) Stock Price” was published by Equities Focus and is owned by of Equities Focus. If you are accessing this piece of content on another domain, it was stolen and reposted in violation of international copyright & trademark laws. The correct version of this piece of content can be accessed at https://www.equitiesfocus.com/2018/03/14/omnicare-ocr-getting-somewhat-positive-media-coverage-report-finds.html.
Omnicare Company Profile
Omnicare, Inc is a healthcare services company that specializes in the management of complex pharmaceutical care. The Company operates two primary businesses, Long-Term Care Group (LTC) and Specialty Care Group (SCG), each serving different customer populations. Through LTC, the Company is a provider of pharmaceuticals and related pharmacy and ancillary services to long-term care facilities, as well as chronic care facilities and other settings.
Receive News & Ratings for Omnicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omnicare and related companies with MarketBeat.com's FREE daily email newsletter.